Pre-IPO Review
Pre-IPO ReviewAggregating reviews, news, and community signal on pre-IPO companies

Synchron

🧬 BCI/Biotech

Endovascular BCI implanted via blood vessels — no open-brain surgery

BCIEndovascularStentrode
$0.5B
Latest valuation
👀 0💬 0
Valuation
$0.5B
Total Funding
$345.00M
Founded
2012
HQ
New York, NY
📊 View full data on Sacra →

📰 Company News

Synchron's Stentrode Advances Brain-Computer Interface Technology
via QR Code Press·2026-08-04↗
Synchron Hires Senior Quality Engineer for New Product Development
via LinkedIn·2026-07-08↗
Synchron seeks Senior R&D Engineer with competitive salary range
via LinkedIn·2026-07-05↗

🤝 Related Companies

Colossal Biosciences
$10.2B
👀 0💬 0
Neuralink
$9.65B
👀 0💬 1
Isomorphic Labs
$5B
👀 0💬 0
Altos Labs
$3B
👀 0💬 0
Insitro
$2.57B
👀 0💬 0
Generate Biomedicines
$2B
👀 0💬 0

📰 Articles

No articles yet. Be the first to share one.

Reviews (0)

🔥 Most Helpful🕐 Newest
No reviews yet. Be the first.